ATRX and neoplasm: In osteosarcoma, mutations in ATRX lead to upregulation of NF-κB, extracellular matrix remodeling, increased B3 integrin expression, and more aggressive tumor cell phenotypes, including increased growth, migration, invasion, and metastasis [5].